
Padmavathi Baskar
Examiner (ID: 13817, Phone: (571)272-0853 , Office: P/1645 )
| Most Active Art Unit | 1645 |
| Art Unit(s) | 1641, 1645 |
| Total Applications | 1590 |
| Issued Applications | 1047 |
| Pending Applications | 159 |
| Abandoned Applications | 391 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 4872722
[patent_doc_number] => 20080199456
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-21
[patent_title] => 'COMPOUNDS AND METHODS FOR TREATMENT AND DIAGNOSIS OF CHLAMYDIAL INFECTION'
[patent_app_type] => utility
[patent_app_number] => 11/928463
[patent_app_country] => US
[patent_app_date] => 2007-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42636
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0199/20080199456.pdf
[firstpage_image] =>[orig_patent_app_number] => 11928463
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/928463 | COMPOUNDS AND METHODS FOR TREATMENT AND DIAGNOSIS OF CHLAMYDIAL INFECTION | Oct 29, 2007 | Abandoned |
Array
(
[id] => 5446057
[patent_doc_number] => 20090047283
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-19
[patent_title] => 'COMPOUNDS AND METHODS FOR TREATMENT AND DIAGNOSIS OF CHLAMYDIAL INFECTION'
[patent_app_type] => utility
[patent_app_number] => 11/928477
[patent_app_country] => US
[patent_app_date] => 2007-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42634
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0047/20090047283.pdf
[firstpage_image] =>[orig_patent_app_number] => 11928477
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/928477 | COMPOUNDS AND METHODS FOR TREATMENT AND DIAGNOSIS OF CHLAMYDIAL INFECTION | Oct 29, 2007 | Abandoned |
Array
(
[id] => 6196149
[patent_doc_number] => 20110027907
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-03
[patent_title] => 'SSL7 MUTANTS AND USES THEREFOR'
[patent_app_type] => utility
[patent_app_number] => 12/445675
[patent_app_country] => US
[patent_app_date] => 2007-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 12206
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0027/20110027907.pdf
[firstpage_image] =>[orig_patent_app_number] => 12445675
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/445675 | SSL7 MUTANTS AND USES THEREFOR | Oct 17, 2007 | Abandoned |
Array
(
[id] => 6228940
[patent_doc_number] => 20100183678
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-22
[patent_title] => 'CONJUGATES OF PLASMODIUM FALCIPARUM SURFACE PROTEINS AS MALARIA VACCINES'
[patent_app_type] => utility
[patent_app_number] => 12/444963
[patent_app_country] => US
[patent_app_date] => 2007-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 9750
[patent_no_of_claims] => 59
[patent_no_of_ind_claims] => 41
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0183/20100183678.pdf
[firstpage_image] =>[orig_patent_app_number] => 12444963
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/444963 | Conjugates of Plasmodium falciparum surface proteins as malaria vaccines | Oct 14, 2007 | Issued |
Array
(
[id] => 6280213
[patent_doc_number] => 20100119485
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-13
[patent_title] => 'NOVEL METHOD FOR BIOLOGICALLY COMBATING THE PROLIFERATION OF LEGIONELLA PNEUMOPHILA, AND NOVEL DISINFECTING AGENT CONTAINING AMOEBIC PROTOZOA OF THE WILLAERTIA GENUS'
[patent_app_type] => utility
[patent_app_number] => 12/311748
[patent_app_country] => US
[patent_app_date] => 2007-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 4601
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0119/20100119485.pdf
[firstpage_image] =>[orig_patent_app_number] => 12311748
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/311748 | Method for biologically combating the proliferation of Legionella pneumophila, and novel disinfecting agent containing amoebic protozoa of the Willaertia genus | Oct 11, 2007 | Issued |
Array
(
[id] => 4903552
[patent_doc_number] => 20080112965
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-15
[patent_title] => 'Chlamydia OMP antigen'
[patent_app_type] => utility
[patent_app_number] => 11/907155
[patent_app_country] => US
[patent_app_date] => 2007-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 97
[patent_figures_cnt] => 97
[patent_no_of_words] => 14883
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0112/20080112965.pdf
[firstpage_image] =>[orig_patent_app_number] => 11907155
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/907155 | Chlamydia OMP antigen | Oct 9, 2007 | Abandoned |
Array
(
[id] => 4845481
[patent_doc_number] => 20080181889
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-31
[patent_title] => 'PREVENTION OF CHLAMYDIA INFECTION USING A PROTECTIVE ANTIBODY'
[patent_app_type] => utility
[patent_app_number] => 11/868788
[patent_app_country] => US
[patent_app_date] => 2007-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 20150
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0181/20080181889.pdf
[firstpage_image] =>[orig_patent_app_number] => 11868788
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/868788 | Prevention of chlamydia infection using SIRNA | Oct 7, 2007 | Issued |
Array
(
[id] => 4965289
[patent_doc_number] => 20080108109
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-08
[patent_title] => 'Biosynthesis of TA antibiotic'
[patent_app_type] => utility
[patent_app_number] => 11/905592
[patent_app_country] => US
[patent_app_date] => 2007-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6497
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0108/20080108109.pdf
[firstpage_image] =>[orig_patent_app_number] => 11905592
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/905592 | Biosynthesis of TA antibiotic | Oct 1, 2007 | Abandoned |
Array
(
[id] => 4915193
[patent_doc_number] => 20080095793
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-04-24
[patent_title] => 'Chlamydia flagellar protein antigen'
[patent_app_type] => utility
[patent_app_number] => 11/905430
[patent_app_country] => US
[patent_app_date] => 2007-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 97
[patent_figures_cnt] => 97
[patent_no_of_words] => 14883
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0095/20080095793.pdf
[firstpage_image] =>[orig_patent_app_number] => 11905430
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/905430 | Chlamydia flagellar protein antigen | Sep 30, 2007 | Issued |
Array
(
[id] => 9183884
[patent_doc_number] => 08623816
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-01-07
[patent_title] => 'Compositions and methods for treating malaria with cupredoxin and cytochrome'
[patent_app_type] => utility
[patent_app_number] => 11/861536
[patent_app_country] => US
[patent_app_date] => 2007-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 20864
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11861536
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/861536 | Compositions and methods for treating malaria with cupredoxin and cytochrome | Sep 25, 2007 | Issued |
Array
(
[id] => 122423
[patent_doc_number] => 07704711
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2010-04-27
[patent_title] => 'Human protein kinases and uses therefor'
[patent_app_type] => utility
[patent_app_number] => 11/901873
[patent_app_country] => US
[patent_app_date] => 2007-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 58
[patent_figures_cnt] => 58
[patent_no_of_words] => 37280
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/704/07704711.pdf
[firstpage_image] =>[orig_patent_app_number] => 11901873
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/901873 | Human protein kinases and uses therefor | Sep 18, 2007 | Issued |
Array
(
[id] => 7800895
[patent_doc_number] => 08129165
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-03-06
[patent_title] => 'Borrelia antigens'
[patent_app_type] => utility
[patent_app_number] => 12/440161
[patent_app_country] => US
[patent_app_date] => 2007-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 12
[patent_no_of_words] => 58517
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/129/08129165.pdf
[firstpage_image] =>[orig_patent_app_number] => 12440161
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/440161 | Borrelia antigens | Sep 13, 2007 | Issued |
Array
(
[id] => 5374691
[patent_doc_number] => 20090312252
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-17
[patent_title] => 'Antimicrobial Activity in Variants of Lacritin'
[patent_app_type] => utility
[patent_app_number] => 12/441178
[patent_app_country] => US
[patent_app_date] => 2007-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 16933
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0312/20090312252.pdf
[firstpage_image] =>[orig_patent_app_number] => 12441178
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/441178 | Antimicrobial Activity in Variants of Lacritin | Sep 12, 2007 | Abandoned |
Array
(
[id] => 6625897
[patent_doc_number] => 20100034850
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-11
[patent_title] => 'VACCINE'
[patent_app_type] => utility
[patent_app_number] => 12/440054
[patent_app_country] => US
[patent_app_date] => 2007-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 19563
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0034/20100034850.pdf
[firstpage_image] =>[orig_patent_app_number] => 12440054
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/440054 | Vaccine | Sep 6, 2007 | Issued |
| 10/591395 | Immunogenic Compositions for Chlamydia Pneunoniae | Aug 21, 2007 | Abandoned |
Array
(
[id] => 5484952
[patent_doc_number] => 20090274717
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-11-05
[patent_title] => 'Genes and proteins, and their use'
[patent_app_type] => utility
[patent_app_number] => 11/892024
[patent_app_country] => US
[patent_app_date] => 2007-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5508
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0274/20090274717.pdf
[firstpage_image] =>[orig_patent_app_number] => 11892024
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/892024 | Genes and proteins, and their use | Aug 16, 2007 | Abandoned |
Array
(
[id] => 6412991
[patent_doc_number] => 20100166788
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-01
[patent_title] => 'IMMUNOGENS FROM UROPATHOGENIC ESCHERICHIA COLI'
[patent_app_type] => utility
[patent_app_number] => 12/377572
[patent_app_country] => US
[patent_app_date] => 2007-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23137
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20100166788.pdf
[firstpage_image] =>[orig_patent_app_number] => 12377572
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/377572 | IMMUNOGENS FROM UROPATHOGENIC ESCHERICHIA COLI | Aug 14, 2007 | Abandoned |
Array
(
[id] => 270647
[patent_doc_number] => 07563883
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-07-21
[patent_title] => 'Recombinant P. falciparum merozoite protein-142 vaccine'
[patent_app_type] => utility
[patent_app_number] => 11/889578
[patent_app_country] => US
[patent_app_date] => 2007-08-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 17
[patent_no_of_words] => 16908
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/563/07563883.pdf
[firstpage_image] =>[orig_patent_app_number] => 11889578
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/889578 | Recombinant P. falciparum merozoite protein-142 vaccine | Aug 13, 2007 | Issued |
Array
(
[id] => 4739470
[patent_doc_number] => 20080233123
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-25
[patent_title] => 'Polypeptide from haemophilus influenzae'
[patent_app_type] => utility
[patent_app_number] => 11/890396
[patent_app_country] => US
[patent_app_date] => 2007-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 22732
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0233/20080233123.pdf
[firstpage_image] =>[orig_patent_app_number] => 11890396
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/890396 | Polypeptide from haemophilus influenzae | Aug 5, 2007 | Abandoned |
Array
(
[id] => 4938834
[patent_doc_number] => 20080076153
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-03-27
[patent_title] => 'Nucleic acid and amino acid sequences relating to Staphylococcus epidermidis for diagnostics and therapeutics'
[patent_app_type] => utility
[patent_app_number] => 11/882810
[patent_app_country] => US
[patent_app_date] => 2007-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27895
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0076/20080076153.pdf
[firstpage_image] =>[orig_patent_app_number] => 11882810
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/882810 | Nucleic acid and amino acid sequences relating to Staphylococcus epidermidis for diagnostics and therapeutics | Aug 5, 2007 | Issued |